Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New compounds synthesized at JT promote osteogenesis

May 28, 1999

Cenestin expected to be available in pharmacies by June 1, 1999

May 28, 1999

Bayer and Takeda launch cerivastatin in Japan

May 28, 1999

Viagra is effective in treating ED in men with depression

May 28, 1999

Banyu describes new neuropeptide Y5 receptor antagonists

May 27, 1999

Novo Nordisk receives positive opinion from CPMP on rapid-onset insulin product

May 27, 1999

New dose of Baycol approved in the U.S. for treatment of hypercholesterolemia

May 27, 1999

NPS Pharmaceuticals' calcimimetic enters Japanese development

May 27, 1999

Avandia receives FDA approval for treatment of type II diabetes

May 26, 1999

News from APA: bupropion SR suggested to hold promise as an antiobesity treatment

May 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...